Registration answers one question: is this product safe, effective and of good quality? Market access answers another: will health systems pay for it, and at what price? In the GCC, both questions should be answered together.
Why sequencing matters
Reference pricing: authorities often compare prices across countries, so the first price set influences every market that follows.
Formulary listing: hospital and payer formularies expect clinical and economic justification.
Tender prices: public procurement prices interact with registered and listed prices.
Value evidence: decision-makers increasingly expect health economic and real-world evidence adapted to the local population.
Building the access plan
Map pricing rules and reference baskets for each target market.
Define the launch sequence to protect price integrity.
Prepare a value dossier with clinical, economic and budget-impact evidence.
Adapt global economic models to local costs and epidemiology.
Plan stakeholder engagement with payers, clinicians and procurement bodies.
How HERMS supports
HERMS builds GCC market access strategies covering pricing, launch sequencing, value dossiers, budget-impact analysis and formulary submissions.
Before you set your first GCC price, talk to HERMS about launch sequencing. Contact HERMS →